Abstract:The coronavirus disease 2019 (COVID-19) pandemic caused extensive loss of life worldwide. Further, the COVID-19 and influenza mix-infection had caused great distress to the diagnosis of the disease. To control illness progression and limit viral spread within the population, a real-time reverse-transcription PCR (RT-PCR) assay for early diagnosis of COVID-19 was developed, but detection was time-consuming (4-6 h). To improve the diagnosis of COVID-19 and influenza, we herein developed a recombinase polymerase amplification (RPA) method for simple and rapid amplification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 and Influenza A (H1N1, H3N2) and B (influenza B). Genes encoding the matrix protein (M) for H1N1, and the hemagglutinin (HA) for H3N2, and the polymerase A (PA) for Influenza B, and the nucleocapsid protein (N), the RNA-dependent-RNA polymerase (RdRP) in the open reading frame 1ab (ORF1ab) region, and the envelope protein (E) for SARS-CoV-2 were selected, and specific primers were designed. We validated our method using SARS-CoV-2, H1N1, H3N2 and influenza B plasmid standards and RNA samples extracted from COVID-19 and Influenza A/B (RT-PCR-verified) positive patients. The method could detect SARS-CoV-2 plasmid standard DNA quantitatively between 10(2) and 10(5) copies/ml with a log linearity of 0.99 in 22 min. And this method also be very effective in simultaneous detection of H1N1, H3N2 and influenza B. Clinical validation of 100 cases revealed a sensitivity of 100% for differentiating COVID-19 patients from healthy controls when the specificity was set at 90%. These results demonstrate that this nucleic acid testing method is advantageous compared with traditional PCR and other isothermal nucleic acid amplification methods in terms of time and portability. This method could potentially be used for detection of SARS-CoV-2, H1N1, H3N2 and influenza B, and adapted for point-of-care (POC) detection of a broad range of infectious pathogens in resource-limited settings.

SEDphone: Spatial Encoding of Centrifugal Microfluidic Disc Integrated Smartphone-Controlled Platform Via RT/LAMP-CRISPR/Cas12a System for Influenza Virus Subtypes Detection

Simultaneous detection of influenza A, influenza B, and respiratory syncytial viruses and subtyping of influenza A H3N2 virus and H1N1 (2009) virus by multiplex real-time PCR.

HCR-Assisted RTF-EXPAR-Based Lateral Flow Analysis for Sensitive Detection of H1N1 Influenza Virus

An integrated dual-layer microfluidic platform for multiple respiratory viruses screening

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

Detection and identification of SARS-CoV-2 and Influenza A based on microfluidic technology

An automated nucleic acid detection platform using digital microfluidics with an optimized Cas12a system

Simultaneous detection of multiple influenza virus subtypes based on microbead-encoded microfluidic chip

SERS Platform for Integrated Enrichment, Isolation, and Identification of Multiple Respiratory Viruses in a Single Assay Using 3D Stereoscopic SERS Tags and Flocked Swabs

Rapid Detection and Subtyping of Multiple Influenza Viruses on a Microfluidic Chip Integrated with Controllable Micro-Magnetic Field.

A Precise and Portable Detection System for Infectious Pathogens Based on CRISPR/Cas Technology

Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay

An electrochemical, fluorescent, and colorimetric triple-mode homogeneous biosensor for the simultaneous detection of influenza A, influenza B, and SARS-CoV-2

Design and application of a point-of-care testing system for triple detection of SARS-CoV-2, influenza A, and influenza B

Point-of-Care Multiplex Detection of Respiratory Viruses

Infectious Disease Diagnosis and Pathogen Identification Platform Based on Multiplex Recombinase Polymerase Amplification-Assisted CRISPR-Cas12a System

CRISPR-Based Assays for Point-of-Need Detection and Subtyping of Influenza

Portable and simultaneous detection of four respiratory pathogens through a microfluidic LAMP and real-time fluorescence assay

Clinical Evaluation of a Novel Digital Microfluidic Based Point-of-care Test Platform for Detection of SARS-Cov-2 and Influenza A/B

Rapid Detection of Influenza Virus Subtypes Based on an Integrated Centrifugal Disc.

Simultaneous detection of SARS-CoV-2 and influenza A/B viruses on an electromagnetically-driven, integrated microfluidic system